| __timestamp | MorphoSys AG | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 77000 | 17293000 |
| Thursday, January 1, 2015 | 77000 | 26470000 |
| Friday, January 1, 2016 | 97000 | 28307000 |
| Sunday, January 1, 2017 | 33000 | 30354000 |
| Monday, January 1, 2018 | 1796629 | 32160000 |
| Tuesday, January 1, 2019 | 12085198 | 37571000 |
| Wednesday, January 1, 2020 | 9174146 | 39951000 |
| Friday, January 1, 2021 | 32200000 | 50159000 |
| Saturday, January 1, 2022 | 48620000 | 54577000 |
| Sunday, January 1, 2023 | 58355000 | 61940000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. Over the past decade, MorphoSys AG and Vericel Corporation have shown distinct trajectories in their cost of revenue. From 2014 to 2023, MorphoSys AG's cost of revenue surged by an astounding 75,000%, starting from a modest $77,000 to a staggering $58.4 million. This reflects their aggressive expansion and investment in research and development. In contrast, Vericel Corporation's cost of revenue grew by 258%, from $17.3 million to $61.9 million, indicating a steady and strategic scaling of operations. Notably, both companies experienced significant growth post-2018, with Vericel consistently outpacing MorphoSys in absolute terms. This trend highlights the competitive nature of the biotech industry, where strategic financial management can be as crucial as scientific innovation.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Vericel Corporation
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Bio-Techne Corporation vs Vericel Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Exelixis, Inc. and MorphoSys AG's Expenses
Cost of Revenue Trends: Grifols, S.A. vs MorphoSys AG
MorphoSys AG vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: MorphoSys AG vs Celldex Therapeutics, Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.